CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 187 filers reported holding CRISPR THERAPEUTICS AG in Q3 2018. The put-call ratio across all filers is 2.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,481,008 | -20.5% | 27,421 | +0.3% | 0.22% | -26.4% |
Q1 2024 | $1,863,563 | +2.4% | 27,341 | -6.0% | 0.30% | -14.0% |
Q4 2023 | $1,820,345 | +48.6% | 29,079 | +7.7% | 0.34% | +36.0% |
Q3 2023 | $1,225,394 | -17.7% | 26,997 | +1.7% | 0.25% | -10.0% |
Q2 2023 | $1,489,675 | +28.2% | 26,535 | +3.3% | 0.28% | +19.1% |
Q1 2023 | $1,161,687 | +112.3% | 25,684 | +90.8% | 0.24% | +218.9% |
Q4 2022 | $547,068 | -34.4% | 13,458 | +5.5% | 0.07% | -63.5% |
Q3 2022 | $834,000 | +211.2% | 12,756 | +189.5% | 0.20% | +275.9% |
Q2 2022 | $268,000 | +90.1% | 4,406 | +95.9% | 0.05% | +116.0% |
Q1 2022 | $141,000 | +50.0% | 2,249 | +81.7% | 0.02% | +56.2% |
Q4 2021 | $94,000 | -21.0% | 1,238 | +16.8% | 0.02% | -23.8% |
Q3 2021 | $119,000 | -30.8% | 1,060 | 0.0% | 0.02% | -32.3% |
Q2 2021 | $172,000 | +29.3% | 1,060 | -2.8% | 0.03% | +3.3% |
Q1 2021 | $133,000 | +0.8% | 1,090 | +26.9% | 0.03% | -9.1% |
Q4 2020 | $132,000 | +26.9% | 859 | -30.7% | 0.03% | -2.9% |
Q3 2020 | $104,000 | -91.4% | 1,239 | -92.5% | 0.03% | -92.7% |
Q2 2020 | $1,212,000 | +42.1% | 16,492 | -18.0% | 0.46% | +19.0% |
Q1 2020 | $853,000 | -26.9% | 20,105 | +4.9% | 0.39% | -11.0% |
Q4 2019 | $1,167,000 | +37.0% | 19,160 | -7.8% | 0.44% | +14.4% |
Q3 2019 | $852,000 | -26.3% | 20,780 | -15.7% | 0.38% | -23.2% |
Q2 2019 | $1,156,000 | +40.1% | 24,644 | +6.7% | 0.50% | +18.0% |
Q1 2019 | $825,000 | +2.9% | 23,086 | -17.8% | 0.42% | -19.9% |
Q4 2018 | $802,000 | +2067.6% | 28,072 | +3302.7% | 0.53% | +2300.0% |
Q3 2018 | $37,000 | -97.5% | 825 | -97.6% | 0.02% | -98.0% |
Q1 2018 | $1,476,000 | +1062.2% | 34,107 | +597.5% | 1.09% | +1049.5% |
Q4 2017 | $127,000 | – | 4,890 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |